Geert D.
- Country
- The Netherlands
- Department
- Gastroenterology and Hepatology
Research Overview
- A randomized, double-blind, placebo controlled, dose finding study to assess the efficacy and safety of SAR443122 in adult patients with moderate to severe ulcerative colitis
- Evaluation of BI 764532 Uptake in Tumors of Patients with Large Cell Neuroendocrine Lung Carcinoma, Neuroendocrine Carcinoma, or Small Cell Lung Carcinoma
- Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Duvakitug for Induction Therapy in Moderately to Severely Active Crohn's Disease
Data & Insights
Has run more than one trial at 386 of 678 partner sites.
Specializations
Inflammatory Bowel Disease Management
This investigator specializes in treating complex inflammatory bowel conditions, with particular emphasis on both Crohn's disease and ulcerative colitis. Their research encompasses innovative therapeutic approaches for managing these chronic conditions.
- Advanced Therapeutics in Crohn's Disease
- Ulcerative Colitis Treatment Strategies
- Perianal Fistula Management
Novel Treatment Modalities
The investigator focuses on evaluating emerging biological therapies and novel therapeutic compounds, including monoclonal antibodies and targeted small molecules for inflammatory bowel conditions.
- Biological Response Modifiers
- Combination Therapy Approaches
- Long-term Treatment Outcomes
Clinical Assessment Innovation
Their work includes developing and implementing advanced diagnostic imaging techniques and evaluation methods for monitoring disease progression and treatment response in inflammatory bowel conditions.
- Disease Activity Assessment
- Treatment Target Optimization
- Therapeutic Response Monitoring
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.